Heartflow, Inc. Common Stock(HTFL)Earnings, Financials & Key Ratios

Key Thesis Takeaways

• HeartFlow demonstrates impressive top-line momentum with 41.3% year-over-year revenue growth in 2026Q1, yet the company's reliance on a high-cost, human-in-the-loop diagnostic model continues to drive persistent operating losses.
• While gross margins have expanded to 80.2%, the inability to achieve operating leverage suggests that the current cost structure remains fundamentally misaligned with revenue scale.
• Investors should monitor the company's precarious liquidity position, as the rapid depletion of cash reserves to $19.7M in 2026Q1 creates significant execution risk and potential for further dilutive financing.